Viewing Study NCT05736835


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-01-21 @ 11:55 AM
Study NCT ID: NCT05736835
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2023-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Sponsor: CyanVac LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None intranasal vaccine View